Commentary Open Access
Volume 3 | Issue 1 | DOI: https://doi.org/10.33696/haematology.3.044
Commentary on “Dynamics of Erythrocyte Deformation Properties in Wistar Rats During Postnatal Ontogeny”
Katiukhin LN1,*
- 1Sechenov Institute of Evolutionary Physiology and Biochemistry, Russian Academy of Sciences, t(IEPhB RAS) 44 Thorez Avenue, Saint-Petersburg, 194223, Russian Federation
Corresponding Author
Katiukhin LN, lion@iephb.ru
Received Date: March 16, 2022
Accepted Date: April 07, 2022
Al-Akhrass H, Pasquier N, Ivaska J. SorLA Targeting - A Method to Overcome Therapy Resistance in Breast Cancer. Arch Cancer Biol Ther. 2021;2(2):50-53.
Copyright: © 2021 Al-Akhrass H, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Recommended Articles
Impact of Cisplatin Dosing Regimens on Mammary Tumor Growth in an Animal Model
In a recent paper, we introduced a variant of the classical Simeoni tumor growth model, and illustrated its value in assessing tumor growth in a reproducible mouse model for mammary tumors. Our modification consisted of incorporating delay differential equations in the mathematical formulation of the Simeoni model, to represent the delay in drug action often observed under chemotherapeutic or immunotherapeutic regimens.
The Effect of Glucocorticoids on Angiogenesis in the Treatment of Solid Tumors
Glucocorticoids (GCs) are defined by their role in maintaining glucose homeostasis and natural GCs are a class of corticosteroids secreted by the adrenal cortex. Cortisol is the most important natural GC in humans. Cellular cortisol levels are regulated by the tissue-specific metabolic enzymes 11β-hydroxysteroid dehydrogenase 1 and 2 (11β-HSD 1 and 2); 11β-HSD 1 converts inactive cortisone to active cortisol, while 11β-HSD 2 has the opposite function.
Can Filtration Technology Advance Culture of Circulating Tumor Cells towards Precision Medicine?
Today, cancer is the second leading cause of death, with about 9.6 million deaths globally in 2018 [1]. At the end of the 19th century, Paul Ehrlich contributed a milestone to cancer research by introducing chemotherapy as a promising tumor treatment approach. Since then, cancer treatment has undergone tremendous advances, with chemotherapy still being a widely used cancer treatment method today, however, often associated with severe side effects.
Influence of Clinical Risk Factors on Outcomes in Men with Stage I Non-Seminomatous Germ Cell Tumor Undergoing Robot-Assisted Retroperitoneal Lymph Node Dissection
Retroperitoneal lymph nodes are often the first landing site of metastatic disease in men with testicular cancer. Primary retroperitoneal lymph node dissection (RPLND) for clinical stage I NSGCT can accurately surgically stage patients who may have nodal micrometastases, and in some cases, can serve as the primary therapy when volume of metastasis is low.
Leucocyte-Tumor Cell Hybridization Can Initiate Cancer Metastasis
According to estimates from the International Agency for Research on Cancer, by the year 2030 there will be 22 million new cancer cases and 13 million deaths per year. The main reason for death from cancer is not the initial tumor but it’s metastasis to distant parts of the body, yet this process has remained poorly understood for quite some time.